12844 Federal Register / Vol. 89, No. 34 / Tuesday, February 20, 2024 / Notices 

one member shall be a specialist in the 

rural aspects of one or more of the 

professions or fields listed below. In 

addition, the Secretary designates, as ex 

officio members, representatives from 

other Federal agencies, principally 

agencies that conduct or support health 

care research, as well as Federal officials 

the Secretary may consider appropriate. 

42 U.S.C. 299c(c)(3). 

Seven current members’ terms will 

expire in November 2024. To fill these 

positions, we are seeking individuals 

who: (1) are distinguished in the 

conduct of research, demonstration 

projects, and evaluations with respect to 

health care; (2) are distinguished in the 

fields of health care quality research or 

health care improvement; (3) are 

distinguished in the practice of 

medicine; (4) are distinguished in other 

health professions; (5) represent the 

private health care sector (including 

health plans, providers, and purchasers) 

or are distinguished as administrators of 

health care delivery systems; (6) are 

distinguished in the fields of health care 

economics, information systems, law, 

ethics, business, or public policy; and 

(7) represent the interests of patients 

and consumers of health care, 42 U.S.C. 

299c(c)(2). Individuals are particularly 

sought with experience and success in 

these activities. AHRQ will accept 

nominations to serve on the Council in 

a representative capacity. 

The Council meets in the Washington, 

DC, metropolitan area, generally in 

Rockville, Maryland, approximately 

three times a year to provide broad 

guidance to the Secretary and AHRQ’s 

Director on the direction of and 

programs undertaken by AHRQ. 

Seven individuals will be selected by 

the Secretary to serve on the Council 

beginning with the meeting in the 

spring of 2024. Members generally serve 

3-year terms. Appointments are 

staggered to permit an orderly rotation 

of membership. 

Interested persons may nominate one 

or more qualified persons for 

membership on the Council. Selfnominations are accepted. Nominations 

shall include: (1) a copy of the 

nominee’s resume or curriculum vitae; 

and (2) a statement that the nominee is 

willing to serve as a member of the 

Council. Selected candidates will be 

asked to provide detailed information 

concerning their financial interests, 

consultant positions and research grants 

and contracts, to permit evaluation of 

possible sources of conflict of interest. 

Please note that once a candidate is 

nominated, AHRQ may consider that 

nomination for future positions on the 

Council. 

The Department seeks a broad 

geographic representation. In addition, 

AHRQ conducts and supports research 

concerning priority populations, which 

include: Inner city; rural; low income; 

minority; women; children; elderly; and 

those with special health care needs, 

including those who have disabilities, 

need chronic care, or need end-of-life 

health care. See 42 U.S.C. 299(c). AHRQ 

also includes in its definition of priority 

populations those groups identified in 

section 2(a) of Executive Order 13985 as 

members of underserved communities: 

Black, Latino, and Indigenous and 

Native American persons, Asian 

Americans and Pacific Islanders and 

other persons of color; members of 

religious minorities; lesbian, gay, 

bisexual, transgender, and queer 

(LGBTQ+) persons; persons with 

disabilities; persons who live in rural 

areas; and persons otherwise adversely 

affected by persistent poverty or 

inequality. Nominations of persons with 

expertise in health care for these 

priority populations are encouraged. 

Dated: February 14, 2024. 

Marquita Cullom, 

Associate Director. 

[FR Doc. 2024–03401 Filed 2–16–24; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifiers: CMS–10110] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), Federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information (including each proposed 

extension or reinstatement of an existing 

collection of information) and to allow 

60 days for public comment on the 

proposed action. Interested persons are 

invited to send comments regarding our 

burden estimates or any other aspect of 

this collection of information, including 

the necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions, 

the accuracy of the estimated burden, 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected, and the use of automated 

collection techniques or other forms of 

information technology to minimize the 

information collection burden. 

DATES: Comments must be received by 

April 22, 2024. 

ADDRESSES: When commenting, please 

reference the document identifier or 

OMB control number. To be assured 

consideration, comments and 

recommendations must be submitted in 

any one of the following ways: 

1. Electronically. You may send your 

comments electronically to http://

www.regulations.gov. Follow the 

instructions for ‘‘Comment or 

Submission’’ or ‘‘More Search Options’’ 

to find the information collection 

document(s) that are accepting 

comments. 

2. By regular mail. You may mail 

written comments to the following 

address: CMS, Office of Strategic 

Operations and Regulatory Affairs, 

Division of Regulations Development, 

Attention: Document Identifier/OMB 

Control Number: ll, Room C4–26–05, 

7500 Security Boulevard, Baltimore, 

Maryland 21244–1850. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, please access the CMS PRA 

website by copying and pasting the 

following web address into your web 

browser: https://www.cms.gov/ 

Regulations-and-Guidance/Legislation/

PaperworkReductionActof1995/PRAListing. 

FOR FURTHER INFORMATION CONTACT: 

William N. Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: 

Contents 

This notice sets out a summary of the 

use and burden associated with the 

following information collections. More 

detailed information can be found in 

each collection’s supporting statement 

and associated materials (see 

ADDRESSES). 

CMS–10110 Manufacturer Submission 

of Average Sales Price (ASP) Data for 

Medicare Part B Drugs and Biologicals 

Under the PRA (44 U.S.C. 3501– 

3520), Federal agencies must obtain 

approval from the Office of Management 

and Budget (OMB) for each collection of 

information they conduct or sponsor. 

The term ‘‘collection of information’’ is 

defined in 44 U.S.C. 3502(3) and 5 CFR 

1320.3(c) and includes agency requests 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 89, No. 34 / Tuesday, February 20, 2024 / Notices 12845 

or requirements that members of the 

public submit reports, keep records, or 

provide information to a third party. 

Section 3506(c)(2)(A) of the PRA 

requires Federal agencies to publish a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, before 

submitting the collection to OMB for 

approval. To comply with this 

requirement, CMS is publishing this 

notice. 

Information Collection 

1. Type of Information Collection 

Request: Revision of currently approved 

collection; Title of Information 

Collection: Manufacturer Submission of 

Average Sales Price (ASP) Data for 

Medicare Part B Drugs and Biologicals; 

Use: Section 1847A of the Act requires 

that the Medicare Part B payment 

amounts for covered drugs and 

biologicals not paid on a cost or 

prospective payment basis be based 

upon manufacturers’ average sales price 

data submitted quarterly to the Centers 

for Medicare & Medicaid Services 

(CMS). The reporting requirements are 

specified in 42 CFR part 414 subpart J. 

CMS, specifically, the Division of 

Data Analysis and Market-based Pricing 

(DDAMBP) will utilize the ASP data 

(ASP and number of units sold as 

specific in section 1847A of the Act) to 

determine the Medicare Part B drug 

payment amounts for CY 2005 and 

beyond. The manufacturers submit their 

ASP data for all of their National Drug 

Codes (NDC) for Part B drugs. DDAMBP 

compiles the data, analyzes the data and 

runs the data through software to 

calculate the volume-weighted ASP for 

all of the NDCs that are grouped within 

a given HCPCS code. The formula to 

calculate the volume-weighted ASP is 

the Sum (ASP * units) for all NDCs/Sum 

(units * bill units per pkg) for all NDCs. 

DDAMBP provides ASP payment 

amounts for several components within 

CMS that utilize 1847(A) payment 

methodologies to implement various 

payment policies including, but not 

limited to, ESRD, OPPS, OTP and 

payment models. CMS will also use 

reported ASP and units to calculate 

inflation adjusted coinsurance and 

rebates. The Department of Health and 

Human Services’ Office of the Inspector 

General also uses the ASP data in 

conducting studies. Form Number: 

CMS–10110 (OMB Control Number: 

0938–0921); Frequency: Quarterly; 

Affected Public: Private and Business or 

other for-profits; Number of 

Respondents: 500; Number of 

Responses: 2,00; Total Annual Hours: 

26,000. (For policy questions regarding 

this collection contact Felicia Brown at 

(410) 786–9287 or Felicia.brown@

cms.hhs.gov). 

William N. Parham, III, 

Director, Division of Information Collections 

and Regulatory Impacts, Office of Strategic 

Operations and Regulatory Affairs. 

[FR Doc. 2024–03348 Filed 2–16–24; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–10466] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), Federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, and to allow 

a second opportunity for public 

comment on the notice. Interested 

persons are invited to send comments 

regarding the burden estimate or any 

other aspect of this collection of 

information, including the necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions, the accuracy of 

the estimated burden, ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and the use 

of automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

DATES: Comments on the collection(s) of 

information must be received by the 

OMB desk officer by March 21, 2024. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, please access the CMS PRA 

website by copying and pasting the 

following web address into your web 

browser: https://www.cms.gov/ 

Regulations-and-Guidance/Legislation/

PaperworkReductionActof1995/PRAListing. 

FOR FURTHER INFORMATION CONTACT: 

William Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. The term ‘‘collection of 

information’’ is defined in 44 U.S.C. 

3502(3) and 5 CFR 1320.3(c) and 

includes agency requests or 

requirements that members of the public 

submit reports, keep records, or provide 

information to a third party. Section 

3506(c)(2)(A) of the PRA (44 U.S.C. 

3506(c)(2)(A)) requires Federal agencies 

to publish a 30-day notice in the 

Federal Register concerning each 

proposed collection of information, 

including each proposed extension or 

reinstatement of an existing collection 

of information, before submitting the 

collection to OMB for approval. To 

comply with this requirement, CMS is 

publishing this notice that summarizes 

the following proposed collection(s) of 

information for public comment: 

1. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: Patient 

Protection and Affordable Care Act; 

Exchange Functions: Eligibility for 

Exemptions; Use: The data collection 

and reporting requirements in ‘‘Patient 

Protection and Affordable Care Act; 

Exchange Functions: Eligibility for 

Exemptions; Miscellaneous Minimum 

Essential Coverage Provisions’’ (78 FR 

39494 (July 1, 2013)), address Federal 

requirements that states must meet with 

regard to the Exchange minimum 

function of performing eligibility 

determinations and issuing certificates 

of exemption from the shared 

responsibility payment. In the final 

regulation, CMS addresses standards 

related to eligibility, including the 

verification and eligibility 

determination process, eligibility 

redeterminations, options for states to 

rely on HHS to make eligibility 

determinations for certificates of 

exemption, and reporting. CMS 

developed four appendices of 


ddrumheller on DSK120RN23PROD with NOTICES1